Novotech Archives | Page 2 of 3

Home / Posts tagged Novotech (Page 2)

Novotech Releases In-Depth 2023 Global Clinical Trial Landscape Reports on Hemophilia and Primary Biliary Cholangitis

BOSTON, Nov. 02, 2023 (Korea Bizwire) – Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, today released the latest 2023 global clinical trial landscape reports on Primary Biliary Cholangitis (PBC) and Hemophilia. The Novotech research analyst team offers these expert reports monthly at no cost. These reports provide up-to-date information on global clinical trial activity, shedding light [...]

Novotech Announces Key Leadership Appointments: Rick Farris, North America Managing Director and Dr. David Ng, Global Vice President of Biometrics and Data

BOSTON, Oct. 12, 2023 (Korea Bizwire) – Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, announces significant senior executive hires to further expand services for Novotech’s global biotech clients. Rick Farris, a seasoned professional in the clinical research and life sciences industry, has taken on the role of Managing Director for North [...]

Dr. Yooni Kim, Vice President of Clinical Services at Novotech, Delivers Keynote Address at Veeva Korea Summit

SEOUL, Korea, Oct. 12, 2023 (Korea Bizwire) – Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, announced today that Dr. Yooni Kim, Vice President of Clinical Services at Novotech, served as a keynote speaker at the Veeva Korea Summit this week in Seoul, Korea. Novotech has been utilizing Veeva’s technology for over a decade [...]

Novotech Secures Consecutive Frost & Sullivan CRO Company of the Year Award

BOSTON, Oct. 10, 2023 (Korea Bizwire) -- Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, has been selected as the CRO Company of the Year 2023 by growth advisory and opportunity analytics firm Frost & Sullivan. Novotech has been a recipient of the Frost & Sullivan Best Practices awards since 2006. Novotech’s Vice President, [...]

Novotech Appoints Dr. Judith Ng-Cashin as Chief Medical Officer to Drive Global Medical Services

Novotech Brand Video from Novotech on Vimeo. BOSTON, Oct. 03, 2023 (Korea Bizwire) – Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, announced today the appointment of Dr. Judith Ng-Cashin as Chief Medical Officer (CMO). Learn more about Dr. Judith Ng-Cashin here Dr. Ng-Cashin, who brings 20 years of international pharmaceutical, biotech, [...]

Novotech Awarded Cell & Gene Therapy CRO Excellence 2023

SINGAPORE, Sept. 19, 2023 (Korea Bizwire) -- Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities has just been awarded for the second consecutive year the Best CRO for Cell & Gene Therapy 2023 at the Asia Pacific Cell & Gene Therapy Excellence Awards. Novotech’s Vice President, Clinical Services Dr. Yooni Kim accepted the award at [...]

Clinical Trials in China: Unlocking the Potential of Advanced Therapies Presented by Novotech and Endpoints News

BOSTON, Sept. 11, 2023 (Korea Bizwire) – Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, announced today an expert panel webinar on Clinical Trials in China: Unlocking the Potential of Advanced Therapies. Novotech is collaborating with Endpoints News to jointly host this webinar. The webinar will examine how China’s focus on cutting-edge innovations and [...]

Novotech Releases Comprehensive Global Landscape Report on Gallbladder Cancer Clinical Trials

BOSTON, Sept. 7 (Korea Bizwire) – Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, today published the latest specialist clinical trial report –“Gallbladder Cancer: Global Clinical Trials Landscape Report”. According to the report, biopharma companies have initiated approximately 250 ongoing clinical trials in gallbladder cancer (GBC) since 2016, with the Asia-Pacific region [...]

Novotech Publishes Nasopharyngeal Carcinoma Global Clinical Trial Landscape Report

BOSTON, Sept. 7 (Korea Bizwire) – Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, today published the latest specialist clinical trial report – “Nasopharyngeal Carcinoma: Global Clinical Trial Landscape”. According to the report, since 2018, the biopharma industry has initiated over 200 global clinical trials for nasopharyngeal carcinoma (NPC), with 60% of these [...]

Novotech Announced as Finalist for Asia Pacific Cell & Gene Therapy CRO Excellence Awards 2023

SINGAPORE, July 13 (Korea Bizwire) — Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities is a finalist in the Asia Pacific Cell & Gene Therapy Awards 2023. The winner will be announced at the 7th Cell & Gene Therapy World Asia in Singapore on 13 September 2023. Novotech is currently the recipient of the Asia Pacific Cell & Gene Therapy [...]